newest glp 1 medication New GLP-1 Guidelines for Type 2 Diabetes in 2025 How GLP-1 medications are transforming

Wegovy has shown remarkable effectiveness in promoting weight loss, with participants in clinical trials experiencing an average weight reduction of around 15% of their initial body weight

Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome

Methods This analysis did not require ethical approval, and a protocol was not pre-registered

doi: 10.1161/CIRCRESAHA.111.255505 15 HardieDG

Retatrutide is being studied for: Type 2 diabetes MASH(Metabolic Dysfunction-Associated Steatohepatitis), a liver condition caused by fat buildup Heart disease risk reduction Knee osteoarthritis in people with higher body weight More research is needed before doctors know whether retatrutide is safe and effective for these conditions

Holly Wyatt, profesora adjunta asociada en Medicina en la Universidad de Colorado Anschutz